Versions of Louisiana Revised Statutes 22:999.1 - Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications on LawServer 2023 Louisiana Revised Statutes 22:999.1 – Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications 2022 Louisiana Revised Statutes 22:999.1 – Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications 2021 Louisiana Revised Statutes 22:999.1 – Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications 2020 Louisiana Revised Statutes 22:999.1 – Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications 2019 Louisiana Revised Statutes 22:999.1 – Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications 2017 Louisiana Revised Statutes 22:999.1 – Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications 2016 Louisiana Revised Statutes 22:999.1 – Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications 2015 Louisiana Revised Statutes 22:999.1 – Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications 2014 Louisiana Revised Statutes 22:999.1 – Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications 2013 Louisiana Revised Statutes 22:999.1 – Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications